Piroxmol-P is a potent dual-action pharmaceutical formulation combining Piroxicam and Paracetamol. This combination is specifically designed to provide rapid and long-lasting relief from severe pain and inflammation. By utilizing Piroxicam, a powerful Non-Steroidal Anti-Inflammatory Drug (NSAID), alongside the analgesic properties of Paracetamol, Piroxmol-P effectively targets the root causes of physical discomfort, making it a go-to solution for acute and chronic pain management.

This medication is primarily indicated for orthocare and musculoskeletal conditions. It is highly effective in treating symptoms associated with osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. Piroxmol-P works by reducing the hormones that cause inflammation and pain in the body, helping patients regain mobility and improve their overall quality of life. Whether managing joint stiffness or post-traumatic pain, this formulation provides consistent therapeutic results.

The synergistic effect of Piroxicam and Paracetamol in Piroxmol-P ensures that patients experience a comprehensive reduction in both local inflammation and systemic pain. While Piroxicam focuses on reducing swelling and joint tenderness, Paracetamol acts as an effective antipyretic and analgesic to lower fever and manage overall pain levels. This makes Piroxmol-P an essential medication for patients who require a stronger intervention than standard over-the-counter pain relievers.

Manufactured by MK Healthcare under stringent quality controls, Piroxmol-P adheres to international WHO-GMP and ISO standards. The tablets are packaged in a convenient 10x10 blister format, ensuring each dose remains protected and potent. MK Healthcare offers Piroxmol-P for PCD pharma franchise and third-party manufacturing, providing pharmaceutical distributors and healthcare providers with a reliable, high-demand product within the orthopedic and analgesic segments.